Literature DB >> 15883839

Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.

Hélène Vézina1, Francine Durocher, Martine Dumont, Louis Houde, Csilla Szabo, Martine Tranchant, Jocelyne Chiquette, Marie Plante, Rachel Laframboise, Jean Lépine, Heli Nevanlinna, Dominique Stoppa-Lyonnet, David Goldgar, Peter Bridge, Jacques Simard.   

Abstract

The Quebec population contains about six-million French Canadians, descended from the French settlers who colonized "Nouvelle-France" between 1608 and 1765. Although the relative genetic contribution of each of these founders is highly variable, altogether they account for the major part of the contemporary French-Canadian gene pool. This study was designed to analyze the role of this founder effect in the introduction and diffusion of the BRCA1 recurrent R1443X mutant allele. A highly conserved haplotype, observed in 18 French-Canadian families and generated using 17 microsatellite markers surrounding the BRCA1 locus, supports the fact that the R1443X mutation is a founder mutation in the Quebec population. We also performed haplotyping analysis of R1443X carriers on 19 other families from seven different nationalities; although the same alleles are shared for three markers surrounding the BRCA1 gene, distinct haplotypes were obtained in four families, suggesting multiple origins for the R1443X mutation. Ascending genealogies of the 18 French Canadian families and of controls were reconstructed on an average depth of 10 generations. We identified the founder couple with the highest probability of having introduced the mutation in the population. Based on the descending genealogy of this couple, we detected the presence of geographical concentration in the diffusion pattern of the mutation. This study demonstrates how molecular genetics and demogenetic analyses can complement each other to provide findings that could have an impact on public health. Moreover, this approach is certainly not unique to breast cancer genetics and could be used to understand other complex traits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883839     DOI: 10.1007/s00439-005-1297-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  51 in total

1.  Evidence of a founder effect for the protein C gene 3363 inserted C mutation in thrombophilic pedigrees of French origin.

Authors:  P Couture; E G Bovill; C Demers; J Simard; R Delage; B T Scott; J E Valliere; P W Callas; M Jomphe; F R Rosendaal; M Aiach; G L Long
Journal:  Thromb Haemost       Date:  2001-10       Impact factor: 5.249

2.  Frequencies of cystic fibrosis mutations in the Maine population: high proportion of unknown alleles in individuals of French-Canadian ancestry.

Authors:  J K Bayleran; H Yan; C A Hopper; E M Simpson
Journal:  Hum Genet       Date:  1996-08       Impact factor: 4.132

3.  Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

Authors:  S L Neuhausen; A K Godwin; R Gershoni-Baruch; E Schubert; J Garber; D Stoppa-Lyonnet; E Olah; B Csokay; O Serova; F Lalloo; A Osorio; M Stratton; K Offit; J Boyd; M A Caligo; R J Scott; A Schofield; E Teugels; M Schwab; L Cannon-Albright; T Bishop; D Easton; J Benitez; M C King; B A Ponder; B Weber; P Devilee; A Borg; S A Narod; D Goldgar
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

4.  Concerted evolution of the tandemly repeated genes encoding human U2 snRNA (the RNU2 locus) involves rapid intrachromosomal homogenization and rare interchromosomal gene conversion.

Authors:  D Liao; T Pavelitz; J R Kidd; K K Kidd; A M Weiner
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

5.  Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11-q21.

Authors:  T Normand; S Narod; F Labrie; J Simard
Journal:  Hum Mol Genet       Date:  1993-04       Impact factor: 6.150

6.  Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.

Authors:  A M Dunning; M Chiano; N R Smith; J Dearden; M Gore; S Oakes; C Wilson; M Stratton; J Peto; D Easton; D Clayton; B A Ponder
Journal:  Hum Mol Genet       Date:  1997-02       Impact factor: 6.150

7.  A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

Authors:  T Peelen; M van Vliet; A Petrij-Bosch; R Mieremet; C Szabo; A M van den Ouweland; F Hogervorst; R Brohet; M J Ligtenberg; E Teugels; R van der Luijt; A H van der Hout; J J Gille; G Pals; I Jedema; R Olmer; I van Leeuwen; B Newman; M Plandsoen; M van der Est; G Brink; S Hageman; P J Arts; M M Bakker; P Devilee
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

8.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

9.  A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.

Authors:  S Thorlacius; G Olafsdottir; L Tryggvadottir; S Neuhausen; J G Jonasson; S V Tavtigian; H Tulinius; H M Ogmundsdottir; J E Eyfjörd
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

10.  A statistical test for detection of ancestral genetic contributions to disease occurrence in finite populations.

Authors:  W W Hauck; A O Martin
Journal:  Genet Epidemiol       Date:  1984       Impact factor: 2.135

View more
  21 in total

1.  Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

Authors:  Jeffrey N Weitzel; Jessica Clague; Arelis Martir-Negron; Raquel Ogaz; Josef Herzog; Charité Ricker; Chelsy Jungbluth; Cheryl Cina; Paul Duncan; Gary Unzeitig; J Salvador Saldivar; Mary Beattie; Nancy Feldman; Sharon Sand; Danielle Port; Deborah I Barragan; Esther M John; Susan L Neuhausen; Garrett P Larson
Journal:  J Clin Oncol       Date:  2012-12-10       Impact factor: 44.544

2.  Inferring Transmission Histories of Rare Alleles in Population-Scale Genealogies.

Authors:  Dominic Nelson; Claudia Moreau; Marianne de Vriendt; Yixiao Zeng; Christoph Preuss; Hélène Vézina; Emmanuel Milot; Gregor Andelfinger; Damian Labuda; Simon Gravel
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

3.  Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.

Authors:  Jacques Simard; Martine Dumont; Anne-Marie Moisan; Valérie Gaborieau; Hélène Malouin; Francine Durocher; Jocelyne Chiquette; Marie Plante; Denise Avard; Paul Bessette; Claire Brousseau; Michel Dorval; Béatrice Godard; Louis Houde; Yann Joly; Marie-Andrée Lajoie; Gilles Leblanc; Jean Lépine; Bernard Lespérance; Hélène Vézina; Jillian Parboosingh; Roxane Pichette; Louise Provencher; Josée Rhéaume; Daniel Sinnett; Carolle Samson; Jean-Claude Simard; Martine Tranchant; Patricia Voyer; Douglas Easton; Sean V Tavtigian; Bartha-Maria Knoppers; Rachel Laframboise; Peter Bridge; David Goldgar
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

Review 4.  Genetics of breast cancer: a topic in evolution.

Authors:  S Shiovitz; L A Korde
Journal:  Ann Oncol       Date:  2015-01-20       Impact factor: 32.976

5.  Analysis of GADD45A sequence variations in French Canadian families with high risk of breast cancer.

Authors:  Sylvie Desjardins; Geneviève Ouellette; Yvan Labrie; Jacques Simard; Francine Durocher
Journal:  J Hum Genet       Date:  2008-03-19       Impact factor: 3.172

6.  Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer.

Authors:  Francine Durocher; Yvan Labrie; Geneviève Ouellette; Jacques Simard
Journal:  J Hum Genet       Date:  2007-10-18       Impact factor: 3.172

Review 7.  Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges.

Authors:  Denise Avard; Peter Bridge; Lucie M Bucci; Jocelyne Chiquette; Michel Dorval; Francine Durocher; Doug Easton; Béatrice Godard; David Goldgar; Bartha Maria Knoppers; Rachel Laframboise; Bernard Lespérance; Marie Plante; Sean V Tavtigian; Hélène Vézina; Brenda Wilson; Jacques Simard
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

8.  A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families.

Authors:  Patricia N Tonin; Christine M Maugard; Chantal Perret; Anne-Marie Mes-Masson; Diane M Provencher
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

9.  Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families.

Authors:  Frédéric Guénard; Yvan Labrie; Geneviève Ouellette; Charles Joly Beauparlant; Paul Bessette; Jocelyne Chiquette; Rachel Laframboise; Jean Lépine; Bernard Lespérance; Roxane Pichette; Marie Plante; Francine Durocher
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

10.  Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent.

Authors:  Marc Tischkowitz; Nelly Sabbaghian; Nancy Hamel; Carly Pouchet; William D Foulkes; Anne-Marie Mes-Masson; Diane M Provencher; Patricia N Tonin
Journal:  BMC Med Genet       Date:  2013-01-09       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.